Us Macular Degeneration Treatment Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Macular Degeneration Treatment Market was valued at USD 13.5 Billion in 2022 and is projected to reach USD 25.7 Billion by 2030, growing at a CAGR of 8.5% from 2024 to 2030.
The U.S. macular degeneration treatment market is experiencing significant growth, driven by an aging population and advancements in therapeutic options. In 2021, the market generated approximately USD 4.97 billion in revenue and is projected to reach around USD 8.69 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.4%.
Age-related macular degeneration (AMD) is a leading cause of vision loss among Americans aged 65 and older. With the U.S. Census Bureau estimating that the population of seniors will grow from 58 million in 2022 to 82 million by 2050, the prevalence of AMD is expected to rise correspondingly. This demographic shift underscores the increasing demand for effective treatments.
Several pharmaceutical companies are at the forefront of developing and marketing AMD therapies. Regeneron Pharmaceuticals' Eylea has been a cornerstone in AMD treatment, with U.S. sales reaching $4.77 billion in 2024. The recent FDA approval of a higher-dose formulation, Eylea HD, in August 2023, has further solidified its market position. Notably, Regeneron's fourth-quarter earnings saw a significant boost due to the strong demand for this new formulation.
Competition in the AMD treatment landscape is intensifying. Teva Pharmaceutical Industries and Alvotech have announced that the FDA has agreed to review their AVT06 treatment, a potential biosimilar to Eylea. This development could introduce more options for patients and potentially drive down treatment costs.
From a personal perspective, witnessing the evolution of AMD treatments over the past decade has been remarkable. Early interventions primarily focused on slowing disease progression, but today's therapies offer improved efficacy and patient outcomes. The introduction of biosimilars and new formulations not only enhances treatment accessibility but also fosters a competitive market that encourages continuous innovation.
In summary, the U.S. macular degeneration treatment market is poised for substantial growth, propelled by demographic trends and pharmaceutical advancements. As the market expands, patients can anticipate more effective and accessible treatment options in the near future.
Get an In-Depth Research Analysis of the Global Macular Degeneration Treatment Market Size And Forecast [2025-2032]
Â
Bausch Health Companies
Allergan
Novartis
Pfizer
Bayer
Roche
Sanofi
Santen Pharmaceuticals
Regeneron Pharmaceuticals
Kanghong Pharma
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Macular Degeneration Treatment Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Macular Degeneration Treatment Market
Pharmaceuticals
Photodynamic Therapy
Laser Surgery
Ocular Implants
Nutritional Supplements
Dry Age-related Macular Degeneration (AMD)
Wet Age-related Macular Degeneration (AMD)
Intravitreal Injections
Oral Medications
Topical Formulations
Systemic Therapies
Implants and Sustained Release Devices
Age Group
Gender
Comorbidities
Hospital pharmacies
Retail pharmacies
Online pharmacies
Specialty clinics
Physician offices
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Macular Degeneration Treatment Market Research Analysis
1. Introduction of the Global Macular Degeneration Treatment Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Macular Degeneration Treatment Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Macular Degeneration Treatment Market, By Type
6. Global Macular Degeneration Treatment Market, By Application
7. Global Macular Degeneration Treatment Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Macular Degeneration Treatment Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/